Revvity Inc. (RVTY) closed at $147.79 on November 18, 2026, a decline of 0.73% from the prior session. The move added to a broader pullback that has weighed on the life sciences and diagnostics company in recent weeks.
Over the past seven days, Revvity shares have fallen 7.15%, marking one of the more pronounced short-term retreats for the stock. The 30-day performance tells a similar story, with shares down 3.16% over that period.
The company's market capitalization stood at $16.62 billion as of the close. The session's move reflects continued selling pressure across the measured timeframes, with no single-day gain enough to offset the broader trend.
Revvity operates across scientific instrumentation and diagnostics markets. The stock's recent trajectory places it among names experiencing sustained downward momentum heading into the latter part of November 2026.



